Anne Friel

Dr. Anne Friel is a Lecturer in the Department of Pharmaceutical Science and Biotechnology within the Faculty of Science and Health. Her research focuses on cancer biology, particularly exploring mechanisms in breast, endometrial, and prostate cancers. She investigates anticancer agents, hormonal pathways (e.g., progesterone receptors), and exosome-mediated interactions. Her work integrates in vitro models, xenograft tumor studies, and gene expression analysis.

Research interests include cancer stem cells, tumor growth modulation, chemosensitivity, and biomarker discovery. Key areas span molecular oncology, pharmacology, and drug delivery systems. Her studies often address translational applications in cancer therapy and diagnostics.

Publications highlight advancements in understanding progesterone receptor roles in tumor progression and exosome functions in cancer phenotypic transfer. Despite no listed awards, her work has garnered significant citations, reflecting impactful contributions to cancer research.

No formal advisees are listed, and details on grants or labs are omitted here. Her research spans 2001–2019, with notable contributions to anticancer compound efficacy and tumor biology mechanisms.